SARS-antibody-80R-(IgG) |
E24CHA001 |
EnoGene |
Human-,-Human-IgG1. |
EUR 276.5 |
Description: Human, Human IgG1. |
Human IgG antibody Laboratories manufactures the cost of sofia-2-sars antibody reagents distributed by Genprice. The Cost Of Sofia-2-Sars Antibody reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Antibody. Other Cost products are available in stock. Specificity: Cost Category: Of Group: Sofia-2-Sars Antibody
SeroFlash SARS-CoV-2 IgM/IgG Antibody Detection Kit |
EpiGentek |
25 tests |
EUR 399.3 |
SARS-CoV-2 Nucleocapsid Protein IgG Antibody ELISA Kit |
Abclonal |
96T |
EUR 280 |
SARS-CoV-2 Nucleocapsid Protein IgG Antibody ELISA Kit |
Abclonal |
96T |
EUR 280 |
Rabbit IgG Anti SARS-CoV-2 Nucleoprotein Antibody (CR3009) |
The Native Antigen Company |
0.1 |
EUR 489.89 |
|
Description: This is a recombinant monoclonal antibody which has been reformatted using the variable domain sequences of the original Human IgG1 format. |
Rabbit IgG Anti SARS-CoV-2 Nucleoprotein Antibody (CR3009) |
The Native Antigen Company |
0.5 |
EUR 1865.15 |
|
Description: This is a recombinant monoclonal antibody which has been reformatted using the variable domain sequences of the original Human IgG1 format. |
Rabbit IgG Anti SARS-CoV-2 Nucleoprotein Antibody (CR3018) |
The Native Antigen Company |
0.1 |
EUR 489.89 |
Description: This is a chimeric rabbit antibody, made using the variable domain sequences of the original Human IgG1 format. |
Rabbit IgG Anti SARS-CoV-2 Nucleoprotein Antibody (CR3018) |
The Native Antigen Company |
0.5 |
EUR 1865.15 |
Description: This is a chimeric rabbit antibody, made using the variable domain sequences of the original Human IgG1 format. |
Sofia-2-Sars Antibody information
SARS-CoV-2 Antibody (NSP3) |
RQ6300 |
NSJ Bioreagents |
100 ug |
EUR 390.15 |
Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined. ORF1ab, the largest gene, contains overlapping open reading frames that encode polyproteins PP1ab and PP1a. The polyproteins are cleaved to yield 16 nonstructural proteins, NSP1-16. Production of the longer (PP1ab) or shorter protein (PP1a) depends on a -1 ribosomal frameshifting event. The proteins, based on similarity to other coronaviruses, include the papain-like proteinase protein (NSP3), 3C-like proteinase (NSP5), RNA-dependent RNA polymerase (NSP12, RdRp), helicase (NSP13, HEL), endoRNAse (NSP15), 2'-O-Ribose-Methyltransferase (NSP16) and other nonstructural proteins. SARS-CoV-2 nonstructural proteins are responsible for viral transcription, replication, proteolytic processing, suppression of host immune responses and suppression of host gene expression. The RNA-dependent RNA polymerase is a target of antiviral therapies. |
SARS-CoV-2 Antibody (NSP4) |
RQ6301 |
NSJ Bioreagents |
100 ug |
EUR 390.15 |
Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined.~ ORF1ab, the largest gene, contains overlapping open reading frames that encode polyproteins PP1ab and PP1a. The polyproteins are cleaved to yield 16 nonstructural proteins, NSP1-16. Production of the longer (PP1ab) or shorter protein (PP1a) depends on a -1 ribosomal frameshifting event. The proteins, based on similarity to other coronaviruses, include the papain-like proteinase protein (NSP3), 3C-like proteinase (NSP5), RNA-dependent RNA polymerase (NSP12, RdRp), helicase (NSP13, HEL), endoRNAse (NSP15), 2'-O-Ribose-Methyltransferase (NSP16) and other nonstructural proteins. SARS-CoV-2 nonstructural proteins are responsible for viral transcription, replication, proteolytic processing, suppression of host immune responses and suppression of host gene expression. The RNA-dependent RNA polymerase is a target of antiviral therapies. |
SARS-CoV-2 Antibody (NSP7) |
RQ6302 |
NSJ Bioreagents |
100 ug |
EUR 390.15 |
Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined.~ ORF1ab, the largest gene, contains overlapping open reading frames that encode polyproteins PP1ab and PP1a. The polyproteins are cleaved to yield 16 nonstructural proteins, NSP1-16. Production of the longer (PP1ab) or shorter protein (PP1a) depends on a -1 ribosomal frameshifting event. The proteins, based on similarity to other coronaviruses, include the papain-like proteinase protein (NSP3), 3C-like proteinase (NSP5), RNA-dependent RNA polymerase (NSP12, RdRp), helicase (NSP13, HEL), endoRNAse (NSP15), 2'-O-Ribose-Methyltransferase (NSP16) and other nonstructural proteins. SARS-CoV-2 nonstructural proteins are responsible for viral transcription, replication, proteolytic processing, suppression of host immune responses and suppression of host gene expression. The RNA-dependent RNA polymerase is a target of antiviral therapies. |
SARS-CoV-2 Antibody (NSP8) |
RQ6303 |
NSJ Bioreagents |
100 ug |
EUR 390.15 |
Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined.~ ORF1ab, the largest gene, contains overlapping open reading frames that encode polyproteins PP1ab and PP1a. The polyproteins are cleaved to yield 16 nonstructural proteins, NSP1-16. Production of the longer (PP1ab) or shorter protein (PP1a) depends on a -1 ribosomal frameshifting event. The proteins, based on similarity to other coronaviruses, include the papain-like proteinase protein (NSP3), 3C-like proteinase (NSP5), RNA-dependent RNA polymerase (NSP12, RdRp), helicase (NSP13, HEL), endoRNAse (NSP15), 2'-O-Ribose-Methyltransferase (NSP16) and other nonstructural proteins. SARS-CoV-2 nonstructural proteins are responsible for viral transcription, replication, proteolytic processing, suppression of host immune responses and suppression of host gene expression. The RNA-dependent RNA polymerase is a target of antiviral therapies. |
SARS-CoV-2 Antibody (NSP9) |
RQ6304 |
NSJ Bioreagents |
100 ug |
EUR 390.15 |
Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined.~ ORF1ab, the largest gene, contains overlapping open reading frames that encode polyproteins PP1ab and PP1a. The polyproteins are cleaved to yield 16 nonstructural proteins, NSP1-16. Production of the longer (PP1ab) or shorter protein (PP1a) depends on a -1 ribosomal frameshifting event. The proteins, based on similarity to other coronaviruses, include the papain-like proteinase protein (NSP3), 3C-like proteinase (NSP5), RNA-dependent RNA polymerase (NSP12, RdRp), helicase (NSP13, HEL), endoRNAse (NSP15), 2'-O-Ribose-Methyltransferase (NSP16) and other nonstructural proteins. SARS-CoV-2 nonstructural proteins are responsible for viral transcription, replication, proteolytic processing, suppression of host immune responses and suppression of host gene expression. The RNA-dependent RNA polymerase is a target of antiviral therapies. |
SARS-CoV-2 Spike Antibody |
10-2868 |
Fitzgerald |
1 mg |
EUR 1000 |
|
Description: SARS-CoV-2 Spike Antibody, Recombinant Human |
SARS-CoV-2 Spike Antibody |
10-2869 |
Fitzgerald |
1 mg |
EUR 1000 |
|
Description: SARS-CoV-2 Spike Antibody, Recombinant Human |
SARS-CoV-2 Spike Antibody |
10-2870 |
Fitzgerald |
1 mg |
EUR 1000 |
|
Description: SARS-CoV-2 Spike Antibody, Recombinant Human |
SARS-CoV-2 Spike Antibody |
10-2871 |
Fitzgerald |
1 mg |
EUR 1000 |
|
Description: SARS-CoV-2 Spike Antibody, Recombinant Human |
SARS-CoV-2 Spike Antibody |
10-2906 |
Fitzgerald |
1 mg |
EUR 225 |
|
Description: Anti-SARS-CoV-2 Spike Protein Monoclonal antibody |
SARS-CoV-2 Spike Antibody |
10-2907 |
Fitzgerald |
1 mg |
EUR 225 |
|
Description: Anti-SARS-CoV-2 Spike Protein Monoclonal antibody |
SARS-CoV-2 Antibody (ORF3a) |
RQ6295 |
NSJ Bioreagents |
100 ug |
EUR 390.15 |
Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined. ORF3a encodes a viral accessory protein. Based on its similarity to other coronavirus proteins, ORF3a protein is thought to be a protein with ion channel activity (viroporin) that activates the NLRP3 inflammasome. ORF3a may also play a role in virus replication and pathogenesis. |
SARS-CoV-2 Antibody (NSP10) |
RQ6305 |
NSJ Bioreagents |
100 ug |
EUR 390.15 |
Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined.~ ORF1ab, the largest gene, contains overlapping open reading frames that encode polyproteins PP1ab and PP1a. The polyproteins are cleaved to yield 16 nonstructural proteins, NSP1-16. Production of the longer (PP1ab) or shorter protein (PP1a) depends on a -1 ribosomal frameshifting event. The proteins, based on similarity to other coronaviruses, include the papain-like proteinase protein (NSP3), 3C-like proteinase (NSP5), RNA-dependent RNA polymerase (NSP12, RdRp), helicase (NSP13, HEL), endoRNAse (NSP15), 2'-O-Ribose-Methyltransferase (NSP16) and other nonstructural proteins. SARS-CoV-2 nonstructural proteins are responsible for viral transcription, replication, proteolytic processing, suppression of host immune responses and suppression of host gene expression. The RNA-dependent RNA polymerase is a target of antiviral therapies. |
SARS-CoV-2 Antibody (Nucleocapsid) |
RQ6297 |
NSJ Bioreagents |
100 ug |
EUR 390.15 |
Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined. The structural proteins of SARS-CoV-2 include the envelope protein (E), spike or surface glycoprotein (S), membrane protein (M) and the nucleocapsid protein (N). The nucleocapsid phosphoprotein is a structural protein that binds to, protects the viral RNA genome and is involved in packaging the RNA into virus particles. The N protein has been suggested as an antiviral drug target. |
SARS Antibody (CoV) (Spike) |
GWB-31A5B4 |
GenWay Biotech |
0.1 mg |
Ask for price |
|
SARS Antibody (CoV Spike) |
GWB-7E7002 |
GenWay Biotech |
0.1 mg |
Ask for price |
SARS-CoV/ SARS-CoV-2 (COVID-19) spike antibody [1A9] 100 ul |
BSV-COV-AB-02 |
BioServUK |
100 ul |
Ask for price |
Description: SARS-CoV/ SARS-CoV-2 (COVID-19) spike antibody [1A9] (Spike (S2), Monoclonal) |